Rate of reflow and reperfusion induced arrhythmias: Studies with dual coronary perfusion

Cardiovascular Research

Volumn 26, Issue 4, 1992, Pages 316-323

  Ibuki, Chikao ^a   Hearse, David J ^a   Avkiran, Metin ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Dual perfusion; Rat; Rate of reflow; Regional ischaemia; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY BLOOD FLOW; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; ARRHYTHMIA; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; HUMAN; MALE; MYOCARDIAL REPERFUSION INJURY; PERFUSION; RATS; RATS, INBRED STRAINS; REGIONAL BLOOD FLOW; SUPPORT, NON-U.S. GOV'T;

EID: 0026507927     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/26.4.316     Document Type: Article

References (49)

1. Simoons ML, Serruys PW, Van den Brand M, et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 1986;7:717-28.
2. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI phase I) trial. Circulation 1987;75:817-29.
3. Gruppo Italiano per lo studio della streptochinasi nell’infarto miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-401.
4. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989;80:1049-62.
5. Hearse DJ. Ischemia, reperfusion, and the determinants of tissue injury. Cardiovasc Drugs Ther 1990;4:767-76.
6. Battle WE, Naimi S, Avitall B, et al. Distinctive time course of ventricular vulnerability to fibrillation during and after release of coronary ligation. Am J Cardiol 1974;34:42-7.
7. Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 1984; 16:497-518.
8. Bolli R. Mechanism of myocardial “stunning”. Circulation 1990;82:723-38.
9. Kloner RA, Ganóte CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
10. Jennings RB, Reimer KA, Steenberger C. Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion. J Mol Cell Cardiol 1986;18:769-80.
11. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii:349-60.
12. Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63:307-17.
13. Sheehan FH, Epstein SE. Determinants of arrhythmic death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia. Circulation 1982;65:259-64.
14. Yamazaki S, Fujibayashi Y, Rajagopalan RE, Meerbaum S, Corday E. Effects of staged versus sudden reperfusion after acute coronary occlusion in the dog. J Am Coll Cardiol 1986; 7:564-72.
15. Moschos CB, Burke WM, Lehan PH, Oldewurtel HA, Regan TJ. Thrombolytic agents and lysis of coronary artery thrombosis. Cardiovasc Res 1970;4:228-34.
16. Petropoulos PC, Meijne NG. Cardiac function during perfusion of the circumflex coronary artery, with venous blood, low-molecular dextran, or Tyrode solution. Am Heart J 1964;68:370-82.
17. Karsch KR, Hofmann M, Rentrop KP, Blanke H, Schaper W. Thrombolysis in acute experimental myocardial infarction. J Am Coll Cardiol 1983;1:427-35.
18. Schmidt SB, Varghese PJ, Bloom S, Tackee JM, Ross AM. The influence of residual coronary stenosis on size of infarction in a canine preparation. Circulation 1986;73:1354-9.
19. Myears DW, Nohara R, Abendschein DR, Saffitz JE, Sobel BE, Bergmann SR. Compromise of beneficial effects of reperfusion on myocardium supplied by vessels with critical residual stenosis. J Am Coll Cardiol 1988;11:1078-86.
20. Wilson JL, Ramanathan KB, Ingram JA, Mirvis DM. Effects of residual stenosis on infarct size and regional transmural myocardial blood flow after reperfusion. Am Heart J 1988; 116:1523-9.
21. Akaishi M, Weintraub WS, Mercier RJ, Agarwal JB, Schneider RM, Helfant RH. The significance of underlying coronary stenosis for recovery of myocardial function after transient ischemia in the dog. Am Heart J 1986;112:1226-31.
22. Ohkita T, Nagamoto Y, Fujita M, Kuriyama M, Kuroiwa A. Ventricular fibrillation during partial reperfusion following severe myocardial ischemia in the canine model. J Electrocardiol 1990;23:347-58.
23. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21:737-46.
24. Meesmann W. Early arrhythmias and primary ventricular fibrillation after acute myocardial ischaemia in relation to preexisting coronary collaterals. In: Parratt JR, ed. Early arrhythmias resulting from myocardial ischaemia: mechanisms and prevention by drugs. London: Macmillan, 1982:93-112.
25. Bolli R, Myers ML, Zhu -X, Roberts R. Disparity of reperfusion arrhythmias after reversible myocardial ischemia in open chest and conscious dogs. J Am Coll Cardiol 1986;7:1047-56.
26. Avkiran M, Curtis MJ. Independent dual perfusion of left and right coronary arteries in the isolated rat heart. Am J Physiol 1991;261:H2082-90.
27. Halpern MH. The dual blood supply of the rat heart. Am J Anat 1957;101:1-15.
28. Walker MJA, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988;22:447-55.
29. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
30. O’Neill W, Timmis GC, Bourdillon PD, et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986;314:812-8.
31. Topol EJ, O’Neill WW, Langburd AB, et al. A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. Circulation 1987; 75:420-8.
32. Maras P, Grazia ED, Klugmann S, et al. Reperfusion ventricular arrhythmias during intracoronary thrombolysis. Eur Heart J 1986;7(suppl A):23-30.
33. Naimi S, Avitall B, Mieszala J, Levine HJ. Dispersion of effective refractory period during abrupt reperfusion of ischemic myocardium in dogs. Am J Cardiol 1977;39:407-12.
34. Sheridan DJ. Reperfusion-induced arrhythmias: an experimental observation awaiting clinical discovery? In; Hearse DJ, Manning AS, Janse MJ, eds. Life-threatening arrhythmias during ischaemia and infarction. New York: Raven Press, 1987:49-62.
35. Curtis MJ, Hearse DJ. Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol 1989; 21:625-37.
36. Nakata T, Hearse DJ, Curtis MJ. Are reperfusion-induced arrhythmias caused by disinhibition of an arrhythmogenic component of ischemia? J Mol Cell Cardiol 1990;22:843-58.
37. Yamada M, Hearse DJ, Curtis MJ. Reperfusion and readmission of oxygen: pathophysiological relevance of oxygen-derived free radicals to arrhythmogenesis. Circ Res 1990;67:1211-24.
38. Podzuweit T, Binz K-H, Nennstiel P, Flaig W. The anti-arrhythmic effects of myocardial ischaemia. Relation to reperfusion arrhythmias? Cardiovasc Res 1989:23:81-90.
39. Avkiran M, Ibuki C, Hearse DJ. Stepwise normalisation of extracellular pH inhibits reperfusion-induced arrhythmias (abstract). J Mol Cell Cardiol 1991;23(suppl V):S113.
40. Ibuki C, Hearse DJ, Avkiran M. Transient acidic reperfusion and reperfusion-induced arrhythmias: a pH-response study (abstract). J Mol Cell Cardiol 1991;23(suppl V):S10.
41. Hearse DJ. Stunning: a radical re-view. Cardiovasc Drugs Ther 1991;5:853-76.
42. + exchange. Circ Res 1990;66:1156-9.
43. Reeves JP, Bailey CA, Hale CC. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem 1986;261:4948-55.
44. Opie LH, Coetzee WA. Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention. Cardiovasc Drugs Ther 1988;2:623-36.
45. Tanaka K, Hearse DJ. Reperfusion-induced arrhythmias in the isolated rabbit heart: characterization of the influence of the duration of the regional ischemia and the extracellular potassium concentration. J Mol Cell Cardiol 1988;20:201-11.
46. Balke CW, Kaplinsky E, Michelson EL, Naito M, Dreifus LS. Reperfusion ventricular tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia. Am Heart J 1981;101:449-56.
47. Curtis MJ, MacLeod BA, Walker MJA. Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. J Mol Cell Cardiol 1987:19:399-419.
48. Schröck GD, Krahmer RL, Ferguson JL. Coronary flow by left atrial and left ventricular microsphere injection in the rat. Am J Physiol 1990;259:H635-8.
49. Wangler RD, Peters KG, Marcus ML, Tomanek RJ. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res 1982; 51:10-18.